World pharmaceutical market distribution by submarket 2014-2021
This statistic shows the distribution of the total global pharmaceutical market sales from 2014 to 3rd quarter of 2021, by submarket. In 2021, the U.S. pharmaceutical market generated some 47 percent of total global market sales.
Global pharmaceutical market
In 2006, the United States pharmaceutical market accounted for half of the world’s market, with other established markets only accounting for about 37 percent. More recently, the gap between the American market and other markets has shrunk. In 2021, the U.S. market accounted for 47 percent, emerging markets accounted for 24 percent, and Europe totaled 19 percent of the global pharmaceutical market.
Revenue generated by the pharmaceutical market has continued to rise in North America, generating some 555 billion U.S. dollars in 2021. Emerging markets have experienced the largest growth between 2019 and 2021, from 207 up to 285 billion dollars.
In the United States, the pharmaceutical market makes up a small part of overall healthcare spending. Growth in drug expenditures in the United States has also slowed likely due to increased costs for consumers, new generic medication, conversion to over the counter drugs, and safety concerns. A large portion of pharmaceutical expenditure is dedicated to oncologics, respiratory agents, lipid regulators, antidiabetics, and antipsychotics. The world’s pharmaceutical market reached some 1.27 trillion U.S. dollars of revenue in 2020.
Global pharmaceutical market
In 2006, the United States pharmaceutical market accounted for half of the world’s market, with other established markets only accounting for about 37 percent. More recently, the gap between the American market and other markets has shrunk. In 2021, the U.S. market accounted for 47 percent, emerging markets accounted for 24 percent, and Europe totaled 19 percent of the global pharmaceutical market.
Revenue generated by the pharmaceutical market has continued to rise in North America, generating some 555 billion U.S. dollars in 2021. Emerging markets have experienced the largest growth between 2019 and 2021, from 207 up to 285 billion dollars.
In the United States, the pharmaceutical market makes up a small part of overall healthcare spending. Growth in drug expenditures in the United States has also slowed likely due to increased costs for consumers, new generic medication, conversion to over the counter drugs, and safety concerns. A large portion of pharmaceutical expenditure is dedicated to oncologics, respiratory agents, lipid regulators, antidiabetics, and antipsychotics. The world’s pharmaceutical market reached some 1.27 trillion U.S. dollars of revenue in 2020.
